Bayer AG's stock experienced a decline following a series of legal challenges. The Washington state Supreme Court announced it would review a case involving Bayer's Monsanto unit, which is accused of causing brain injuries to three teachers due to exposure to toxic chemicals. This legal setback contributed to a notable drop in Bayer's shares. Additionally, a Philadelphia jury ruled that Bayer must pay $78 million to a Pennsylvania man in a separate case related to its Roundup herbicide, which has been linked to cancer. The combination of these legal issues has raised concerns among investors about Bayer's potential liabilities and future financial performance.
Bayer must pay US$78 million in latest Roundup cancer trial, jury finds https://t.co/5RinzX7p2j
Bayer must pay US$78M to Pennsylvania man in latest Roundup cancer trial, jury finds https://t.co/s9PsskDBzr
Phila. Jury Returns $78M to Plaintiffs in Roundup Case https://t.co/yU1sf25mjU